EP3240805
TVÍSÉRTÆKUR, SÉRVIRKUR EÐAGÁTTARMÓTEFNAVIÐTAKI ER SVARAR CD19 OG CD20
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.12.2015EP published:
27.11.2024EP application number:
15870818.0
EP translation filed:
14.2.2025Grant published:
15.3.2025EPO information:
European Patent Register
Max expiry date:
13.12.2035Expiry date:
13.12.2026Next due date:
31.12.2026
Title in English:
BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 AND CD20Language of the patent:
English
Timeline
Today
14.12.2015EP application
27.11.2024EP Publication
14.2.2025Translation submitted
15.3.2025Registration published
13.12.2026Expires
Owner
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200, US
Name:
Seattle Children's Hospital, dba Seattle Children's Research InstituteAddress:
1900 9th Avenue, Seattle, WA 98101, US
Inventor
Name:
CHEN, Yvonne Y.Address:
Los Angeles, California 90025, US
Name:
ZAH, EugeniaAddress:
Los Angeles, California 90024, US
Name:
JENSEN, Michael C.Address:
Seattle, Washington 98101, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201462091854 PDate:
15.12.2014Country:
US
Classification
Categories:
C07K 16/28, C07K 16/46, C07K 14/705, C12N 15/62, C12N 15/85, C12N 5/0783, A61K 35/17, A61K 38/00, A61K 39/00, C07K 14/725
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 20.1.2025
Expires: 13.12.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.12.2025
Expires: 13.12.2026
Payer: Árnason Faktor ehf.